International trade · 19/05/2026Updated: 10/16/2026 · 1 min read

U.S. International Trade Commission Denies Review of Ascendis Pharma Name Change Decision

The U.S. International Trade Commission has determined not to review an initial determination amending the complaint and notice of investigation to reflect Ascendis Pharma's corporate name change to Ascendis Pharma, LLC.